Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Recommendation of “Buy” by Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $12.25.

BIOX has been the topic of a number of recent analyst reports. Roth Mkm lowered their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, October 17th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Lake Street Capital lowered their price objective on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Finally, Oppenheimer dropped their price objective on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st.

Institutional Investors Weigh In On Bioceres Crop Solutions

Large investors have recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Bioceres Crop Solutions in the 2nd quarter worth about $472,000. Fourth Sail Capital LP grew its position in Bioceres Crop Solutions by 20.5% during the second quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after acquiring an additional 334,195 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new position in shares of Bioceres Crop Solutions during the first quarter worth approximately $139,000. Ping Capital Management Inc. bought a new stake in shares of Bioceres Crop Solutions in the 2nd quarter worth approximately $448,000. Finally, Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at $212,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Down 4.2 %

Bioceres Crop Solutions stock opened at $6.43 on Thursday. The firm has a 50 day simple moving average of $8.07 and a 200 day simple moving average of $10.02. The company has a current ratio of 1.24, a quick ratio of 0.86 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions has a 1-year low of $6.40 and a 1-year high of $14.05. The firm has a market capitalization of $404.13 million, a price-to-earnings ratio of 160.79 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). The company had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.92%. During the same quarter last year, the firm posted ($0.06) earnings per share. On average, analysts predict that Bioceres Crop Solutions will post 0.31 earnings per share for the current year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.